Tom Cotton Questions China's Pharmaceutical Dominance and US Dependence

China's Pharmaceutical Supply Chain Dominance

• 🇨🇳 Communist China controls 80% of the global supply chain for antibiotics and is a major source of essential drugs and active pharmaceutical ingredients (APIs) for the United States.
• ⚠️ This dependence creates a vulnerability, as China could potentially titrate supply based on geopolitical satisfaction, impacting both civilian and military needs, especially for treating combat casualties.

Mitigating Supply Chain Risks

• 🤝 Witnesses suggest leveraging new technologies and forming international consortia with allies like Japan, the EU, and India to broaden and diversify supply chains.
• 🇯🇵 Japan has already invested in API production for drugs like penicillin, presenting an opportunity for the US to partner and sustain such production bases through strategic purchasing.
• 💡 The US should explore options to ally-shore, near-shore, or on-shore critical pharmaceutical manufacturing to reduce reliance on China.

The Role of US Purchasing Power

• 💰 The Departments of Defense (DoD) and Veterans Affairs (VA) possess significant purchasing power that can be used to create a domestic market for essential medicines.
• 📈 A predictable demand signal from these departments is crucial for companies to invest in and build domestic production capabilities, rather than relying on episodic or random demand.

Congressional Action and Future Strategy

• 📋 Congress should direct the DoD to catalog all dependencies on foreign-sourced drugs and APIs, as highlighted by the Uniform Services University and Defense Logistics Agency.
• 🏛️ This cataloging will inform decisions on resilience and National Security, ensuring that troops have access to necessary medicines and reducing strategic vulnerabilities.
• 🇺🇸 Similar to mandated domestic purchases for uniforms, the US should ensure its military has the medicines it needs by fostering domestic production.